|
The Global Bioinformatics Market: Market size, forecasts and company profiles
|
Caracteristicas de este estudio de mercado: | 266 Pages | |||||||||
| Sobre este articulo de mercado: |
The integration of biology and informatics has been very integral part of the life science applications. Changing trends in the drug discovery procedures such as strict regulations in the clinical tes.....
The integration of biology and informatics has been very integral part of the life science applications. Changing trends in the drug discovery procedures such as strict regulations in the clinical testing have forced the drug manufacturers to use effective technologies that will help them to develop successful therapies. The market players are collaborating with each other to develop block buster technologies while utilizing this synergy to reduce cost. This report has covered different regional markets, products and services while evaluating them over the next five years. It provides the information about the largest regional market and factors influencing them, while defining the opportunities they have. Scope of this report • It analyzes the market data ( revenues ) of bioinformatics tools, services and content/database in North America, Europe, Asia and rest of the world that includes Middle East, Africa, Russia, Latin America and Australia • Key market drivers, restraints and opportunities for the parent segments and evaluation of respective sub segments with respect to market dynamics. • Covers sequence analysis, sequence alignment, sequence manipulation and structural analysis under tools market along with the sub segments. Service market includes data analysis, database and management and sequencing services. • Provides patent analysis with respect to competitors, geography and technology while analyzing them over the years. • Describes the strategic focus of the market players by evaluating the competitive landscape within the bioinformatics market. • Analyze the markets while giving an overview of Indian and Chinese bioinformatics industry and mutually comparing them. Key findings from this report • The bioinformatics market growth is highest in the Europe and Asian region, with the European market estimated to compete in the North American bioinformatics market. • North America constitutes the major market share owing to growing demand for bioinformatics tools and technology advancements. • European bioinformatics market is undergoing fast transition from a fragmented market to a consolidated market owing to increasing number of mergers and acquisition taking place. • Sequence analysis tools forms the largest market of the total tools market with its large number of applications in the drug discovery. • Large bioinformatics firms such as Affymetrix and Invitrogen are focusing on acquisitions in order to add more to their product and service portfolio. • Data analysis and sequencing services form the major segment in the bioinformatics service market. Rise in the consultancy services has been the major driving force behind the market growth. Use this report to: • Understand the emerging technologies and the growth associated for evaluation of potential of the type of product and services. • Understanding the product developments on which the companies are focussing for evaluating the new technological trends. • For evaluation of growth prospective for the bioinformatics applications and determining the lucrative markets. • To gain knowledge about the relative importance of the bioinformatics tools in the next five years for investment opportunities. • Helps in determining the market players’ interest in terms of collaborations and M&A with the related industrial firms which will help a company to explore the untouched areas. • Gives an explanatory overview of business environment between India and China, thereby putting an opportunity for the companies to focus on weak business areas. Companies mentioned in the report 3rd MILLENNIUM, INC. , ACCELRYS, INC. , AFFYMETRIX , AGILENT TECHNOLOGIES, INC. , BRUKER DALTONICS INC , ARIADNE GENOMICS , BIODISCOVERY, INC. , BIOINFORMATICS SOLUTIONS INC. , BIOMATTERS LTD , BIOWISDOM LTD , CELERA GENOMIC CORPORATION , CLC BIO , DNASTAR, INC. , GENE LOGIC , GENEGEO , GENEVA BIOINFORMATICS , ILLUMINA INC. , INVITROGEN CORPORATION Report Highlights [Cerrar las informaciones del articulo de mercado] |
|||||||||||
|
Table of Contents Global bioinformatics market Executive summary 20 Market overview 20 Competitive landscape & market dynamics 21 The bioinformatics tools market 22 The bioinformatics 22 The bioinformatics service market 23 The bioinformatics 24 Regional analysis of the bioinformatics 24 Company profiles 25 Chapter 1 Market overview 28 Summary 28 Introduction 29 Defining the bioinformatics market 30 Market evolution increases use of bioinformatics 32 Bioinformatics and drug development 33 Sequencing tools are high priority 37 Bioinformatics database management tools 38 Bioinformatics patent analysis 40 Genomics remains the key segment 40 High market presence of Japanese market players 41 Bioinformatics service outsourcing shifting to Asian markets 42 Market Size 43 Chapter 2 Competitive landscape & market dynamics 46 Summary 46 Introduction 47 Competitive landscape 47 Recent mergers and acquisitions 48 Recent product, technology and service launches 49 Market drivers 54 Need for integrated data-handling tools for drug discovery 54 Growth in genomics and proteomics industry 54 Wide applications in drug discovery and development 54 Government support for R&D 55 Biomarker discovery enables the development of safe drugs 55 Developments in internet and IT 55 Emergence of high-throughput screening 55 Other drivers 56 Resistors of market growth 57 Common, well-defined data formats are needed 57 Need for trained resources compound operational costs 57 Saturation of pharmaceutical markets reduces adoption rate 57 Restricted range of product/service offerings 57 Other restraints to market growth 58 Growth opportunities 58 Pressure to escalate drug research productivity 58 Drug development value chain to widen opportunities 58 High market demand for integrated systems and solutions 58 Chemogenomics poses vast opportunity for growth 59 Applications in diversified areas to expand the user base 59 Data overload in the field of research 59 Chapter 3 The bioinformatics tools market 62 Summary 62 Introduction 63 Growth drivers 66 Need for better output quality in drug discovery 66 Integration of bioinformatics resources 66 Application of bioinformatic tools in the life sciences market 66 Resistors of growth 67 Complex operations of bioinformatic tools restricts growth 67 High price of analytical solutions may not be feasible 67 Sequence analysis tools 67 DNA sequence analysis tools 71 Sequence alignment 72 Gene detection 72 Restriction, and repeats and unusual patterns detection 73 Transcriptional elements detection 73 tRNA detection 74 Protein function assignment 74 Protein-protein interaction 76 Pattern, motif, profiles, domains and families search 76 Search, computation and analysis of pathways 77 Protein annotation 77 Automatic alerts for related new sequences 78 3D structure analysis and modeling tools 78 3D viewers 79 3D homology modeling 79 3D analysis 80 RNA analysis tool 81 Microarray data analysis 81 Phylogenetic analysis 82 Multiple sequence alignment 82 Organism classification 83 Sequence alignment tools 84 Sequence analysis (alignment) 86 Multiple sequence alignment 87 Phylogenetic tree building 87 Consensus sequence and translation 88 Lab end-sequence analysis 89 Primer design 90 Cloning 90 Contig assembly 91 Sequence manipulation tools 91 Sequence analysis (including sequence manipulation) 92 Sequence manipulation 93 Format conversion 94 Random sequences 94 Structural analysis tools 95 Sequence visualization tools 96 3D protein structure 97 Dot plots 97 Graphical and phylogenetic tree viewers and editors 98 Primary sequence analysis 99 Physicochemical property alignment 99 Alignment tools 100 Predicting secondary structure sequences 100 Other bioinformatics tools 101 Visualization tools 102 Database viewers 103 Sequence viewers 103 Molecular viewers 104 Physical mapping software 105 Chapter 4 The bioinformatics content/database market 108 Summary 108 Introduction 109 Growth drivers 111 Exponential growth in the proteomics data and databases 111 Data integration devices needed for in-house solutions 111 Growth in the clinical trials industry supports the market 112 Specialized databases 112 Specialized sequence databases 114 Genome databases 114 Collections 116 Model organism databases 116 Specialized protein databases 117 Proteome databases 118 Protein classification databases 119 Specific protein family databases 119 Specialized structural databases 120 Microarray databases 120 Pathways databases 121 2D-PAGE databases 122 General databases 122 Primary sequence databases 124 Protein sequence databases 124 3D structure databases 125 Carbohydrate databases 125 Chapter 5 The bioinformatics services market 128 Summary 128 Introduction 129 Growth drivers 130 Growing trend towards consultancy 130 Requirement for highly efficient data-mining tools 131 Need for total integration & warehousing solutions 131 Data analysis services 132 Genomics data analysis 134 Proteomics data analysis 134 Microarray data analysis 135 Modeling & computational bioinformatics services 136 Sequencing services 136 High-throughput screening 138 Multiple sequence alignment 139 Resequencing (SNP profiling) 139 Primer walking 140 Expression profile clustering 140 Shotgun sequencing 141 Database management services 142 Conception and realization 144 Development of user interface 144 Maintenance 145 Backup systems 145 Migration 145 Other services 146 Security systems 147 Data-mining services 148 Infrastructure integration services 149 Knowledge management 150 Chapter 6 The bioinformatics applications market 152 Summary 152 Introduction 153 Global market dynamics 153 Growth drivers 154 Rapid development of molecular diagnostics market 154 Development in personalized medicine 154 Specific medicines developed to treat the source of disease 155 Resistors of growth 155 Need for more holistic solutions 155 Bioinformatics considered to be for specialized applications only 155 Opportunities 156 Application in the military 156 Bioinformatics in epidemiology 156 Integration of systems biology with bioinformatics 156 Molecular medicine 157 Global market 158 US 159 Europe 160 Asia 160 Preventive medicine 161 Gene therapy 162 Growth drivers 163 Biomarker discovery helps gene therapy to determine disease candidates 163 Demand for gene therapy treatment necessitates bioinformatics application 163 Opportunities 164 Data proliferation in the field of gene therapy 164 Declining growth of gene therapy market 164 Drug development 164 Growth drivers 165 Drastic cost reduction in the process of drug discovery 165 Data processing needs in the drug development process 165 Virtual high-throughput screening 166 Sequence analysis 166 Similarity searches 166 Drug lead optimization 166 Physicochemical modeling 167 Drug bioavailability and bioactivity 167 Other applications 167 Chapter 7 Regional analysis of the bioinformatics market 172 Summary 172 Introduction 173 North America 173 Europe 174 Asia 175 India and China 176 The Indian bioinformatics industry 178 Business opportunities in India and China 182 Growth drivers 183 Growth resistors 184 Rest of the World 185 Chapter 8 Company profiles 188 Summary 188 3rd Millennium Inc. 189 Company overview 189 Products and services 189 Company strategy 190 Accelrys, Inc. 191 Company overview 191 Products and services 191 Company strategy 191 Affymetrix 192 Company overview 192 Products and services 192 Company strategy 193 Agilent Technologies, Inc. 193 Company overview 193 Products and services 193 Company strategy 194 Animech Technologies AB 195 Company overview 195 Products and services 195 Company strategy 195 Bruker Daltonics inc. 196 Company overview 196 Products and services 196 Company strategy 197 Ariadne Genomics 197 Company overview 197 Products and services 197 Company strategy 198 Biobase GmbH 198 Company overview 199 Products and services 199 Company strategy 199 BioDiscovery, Inc. 200 Company overview 200 Products and services 200 Company strategy 200 Bioinformatics Solutions Inc. 201 Company overview 201 Products and services 201 Company strategy 202 Biomatters Ltd 202 Company overview 202 Products and services 202 Company strategy 203 Biomax Informatics AG 203 Company overview 204 Products and services 204 Company strategy 205 BioWisdom Ltd 205 Company overview 206 Products and services 206 Company strategy 206 Celera Genomics Corporation 207 Company overview 207 Products and services 207 Company strategy 207 CLC bio 208 Company overview 208 Products and services 208 Company strategy 208 Geospiza, Inc. 209 Company overview 209 Products and services 209 Company strategy 210 Clontech Laboratories, Inc. 210 Company overview 210 Products and services 211 Company strategy 211 Definiens AG 211 Company overview 211 Products and services 212 Company strategy 212 DNASTAR, INC. 213 Company overview 213 Products and services 213 Company strategy 213 Expression Analysis, Inc. 214 Company overview 214 Products and services 214 Company strategy 214 Gene Logic 215 Company overview 215 Products and services 215 Company strategy 215 Genedata AG 216 Company overview 216 Products and services 216 Company strategy 217 GeneGo 217 Company overview 217 Products and services 217 Company strategy 218 Geneva Bioinformatics SA 218 Company overview 218 Products and services 219 Company strategy 219 Genologics Life Sciences Software 220 Company overview 220 Products and services 220 Company strategy 220 Genomatix Software Inc. 221 Company overview 221 Products and services 221 Company strategy 221 GenomeQuest, Inc. 222 Company overview 222 Products and services 222 Company strategy 222 Helicos Biosciences Corporation 224 Company overview 224 Products and services 224 Company strategy 224 Illumina Inc. 225 Company overview 225 Products and services 225 Company strategy 226 InforMax Inc. 226 Company overview 226 Products and services 227 Company strategy 227 Nucleics Pvt Ltd 227 Company overview 228 Products and services 228 Company strategy 228 Inforsense Limited 228 Company overview 229 Products and services 229 Company strategy 229 Kinexus Bioinformatics Corporation 229 Company overview 230 Products and services 230 Company strategy 230 MDS Inc. 231 Company overview 231 Products and services 231 Company strategy 231 Miraibio Group 232 Company overview 232 Products and services 232 Company strategy 232 Golden Helix, Inc 233 Company overview 233 Products and services 233 Company strategy 233 Invitrogen Corporation 234 Company overview 234 Products and services 234 Company strategy 234 Molegro 235 Company overview 235 Products and services 235 Company strategy 236 Nonlinear Dynamics 236 Company overview 236 Products and services 236 Company strategy 237 Textco Biosoftware, Inc. 237 Company overview 237 Products and services 238 Company strategy 238 Numerical Algorithms Group Ltd 238 Company overview 238 Products and services 239 Company strategy 239 Ocimum Biosolutions Ltd. 240 Company overview 240 Products and services 240 Company strategy 241 Partek Inc. 241 Company overview 241 Products and services 241 Company strategy 242 Phase Forward Inc. 242 Company overview 242 Products and services 242 Company strategy 243 Premier Biosoft International 243 Company overview 243 Products and services 244 Company strategy 244 Protein Forest Inc. 244 Company overview 245 Products and services 245 Company strategy 245 Rosetta Biosoftware 245 Company overview 245 Products and services 246 Company strategy 246 Silicon Graphics Inc. 247 Company overview 247 Products and services 247 Company strategy 247 Softberry Inc. 248 Company overview 248 Products and services 248 Company strategy 249 Softgenetics, LLC. 249 Company overview 249 Products and services 249 Company strategy 250 Strand Life Sciences 250 Company overview 250 Products and services 250 Company strategy 251 Synamatix Sdn Bhd 251 Company overview 251 Products and services 252 Company strategy 252 Teranode Corporation 252 Company overview 252 Products and services 253 Company strategy 253 Tibco Spotfire 253 Company overview 253 Products and services 253 Company strategy 254 Tripos International 254 Company overview 254 Products and services 254 Company strategy 255 Chapter 9 Appendix 256 Index 265 [Cerrar la tabla de contenidos] |
||||||||||||
|
Table 1.1: Global bioinformatics market by submarket, 2007–14($m) 44 Table 2.2: Recent mergers and acquisitions, 2008–09 49 Table 2.3: New product, technology or service launches, 2008–09 50 Table 2.4: New product, technology or service launches, 2008–09 (contd 1) 51 Table 2.5: New product, technology or service launches, 2008–09 (contd 2) 52 Table 2.6: New product, technology or service launches, 2008–09 (contd 3) 53 Table 3.7: Global bioinformatic tools market by product, 2007–14 ($m) 64 Table 3.8: Bioinformatic tools market by region, 2007–14 ($m) 64 Table 3.9: Global sequence analysis tools market by product function, 69 Table 3.10: Sequence analysis tools market by region, 2007–14 ($m) 70 Table 3.11: Global DNA sequence analysis tools market by product function, 2007–14 ($m) 71 Table 3.12: DNA sequence analysis tools market by region, 2007–14 ($m) 71 Table 3.13: Sequence alignment market by region, 2007–14 ($m) 72 Table 3.14: Gene detection market by region, 2007–14 ($m) 73 Table 3.15: Market for restriction and detection of repeats and unusual patterns by region, 2007– 14 ($m) 73 Table 3.16: Transcriptional elements detection market by region, 2007–14 ($m) 74 Table 3.17: tRNA detection market by region, 2007–14 ($m) 74 Table 3.18: Global protein function assignment market by product function, 2007–14 ($m) 75 Table 3.19: Protein function assignment market by region, 2007–14 ($m) 75 Table 3.20: Protein-protein interactions tools market by region, 2007–14 ($m) 76 Table 3.21: Market for pattern, motif, profiles, domains and families search by region, 2007–14 ($m) 76 Table 3.22: Search, computation and analysis of pathways market by region, 2007–14 ($m) 77 Table 3.23: Protein annotation market by region, 2007–14 ($m) 77 Table 3.24: Automatic alerts for related new sequences market by region, 2007–14 ($m) 78 Table 3.25: Global 3D structure analysis and modeling market by product function, 2007–14 ($m) 78 Table 3.26: 3D structure analysis and modeling market by region, 2007–14 ($m) 79 Table 3.27: 3D viewers market by region, 2007–14 ($m) 79 Table 3.28: 3D homology modeling market by region, 2007–14 ($m) 80 Table 3.29: 3D analysis market by region, 2007–14 ($m) 80 Table 3.30: RNA analysis tool market by region, 2007–14 ($m) 81 Table 3.31: Microarray data analysis market by region, 2007–14 ($m) 81 Table 3.32: Global phylogenetic analysis market by product function, 2007–14 ($m) 82 Table 3.33: Phylogenetic analysis market by region, 2007–14 ($m) 82 Table 3.34: Multiple sequence alignment market by region, 2007–14 ($m) 83 Table 3.35: Organism classification market by region, 2007–14 ($m) 83 Table 3.36: Sequence alignment tools market by product function, 2007–14 ($m) 84 Table 3.37: Sequence alignment tools market by region, 2007–14 ($m) 85 Table 3.38: Sequence analysis (alignment) tools market by product function, 2007–14 ($m) 86 Table 3.39: Sequence analysis (alignment) tools market by region, 2007–14 ($m) 87 Table 3.40: Multiple sequence alignment market by region, 2007–14 ($m) 87 Table 3.41: Phylogenetic tree building market by region, 2007–14 ($m) 88 Table 3.42: Consensus sequence and translation by region, 2007–14 ($m) 88 Table 3.43: Lab end-sequence analysis market by product function, 2007–14 ($m) 89 Table 3.44: Lab end-sequence analysis by region, 2007–14 ($m) 89 Table 3.45: Primer design market by region, 2007–14 ($m) 90 Table 3.46: Cloning market by region, 2007–14 ($m) 91 Table 3.47: Contig assembly market by region, 2007–14 ($m) 91 Table 3.48: Sequence manipulation tools market by product function, 2007–14 ($m) 92 Table 3.49: Sequence manipulation tools market by region, 2007–14 ($m) 92 Table 3.50: Sequence analysis (including sequence manipulation) market by region, 2007–14 ($m) 93 Table 3.51: Sequence manipulation market by region, 2007–14 ($m) 93 Table 3.52: Format conversion market by region, 2007–14 ($m) 94 Table 3.53: Random sequences market by region, 2007–14 ($m) 94 Table 3.54: Global structural analysis tools market by product function, 2007–14 ($m) 95 Table 3.55: Structural analysis tools market by region, 2007–14 ($m) 96 Table 3.56: Global sequence visualization market by product, 2007–14 ($m) 96 Table 3.57: Sequence visualization market by region, 2007–14 ($m) 97 Table 3.58: 3D protein structure market by region, 2007–14 ($m) 97 Table 3.59: Dot plots and others market by region, 2007–14 ($m) 98 Table 3.60: Graphical and phylogenetic tree viewer and editor market by region, 2007–14 ($m) 98 Table 3.61: Primary sequence analysis market by region, 2007–14 ($m) 99 Table 3.62: Physicochemical property alignment market by region, 2007–14 ($m) 100 Table 3.63: Alignment tools market by region, 2007–14 ($m) 100 Table 3.64: Tools to predict secondary structure sequence market by region, 2007–14 ($m) 101 Table 3.65: Global other tools market by product, 2007–14 ($m) 101 Table 3.66: Other tools market by region, 2007–14 ($m) 102 Table 3.67: Visualization tools market by product, 2007–14 ($m) 102 Table 3.68: Visualization tools market by region, 2007–14 ($m) 103 Table 3.69: Database viewers market by region, 2007–14 ($m) 103 Table 3.70: Sequence viewers market by region, 2007–14 ($m) 104 Table 3.71: Molecular viewers market by region, 2007–14 ($m) 104 Table 3.72: Physical mapping software market by region, 2007–14 ($m) 105 Table 4.73: Global content/database market by product, 2007–14 ($m) 110 Table 4.74: Content/database market by region, 2007–14 ($m) 111 Table 4.75: Global specialized database market by product, 2007–14 ($m) 113 Table 4.76: Specialized database market by region, 2007–14 ($m) 113 Table 4.77: Specialized sequence databases market by region, 2007–14 ($m) 114 Table 4.78: Global genome databases market by product, 2007–14 ($m) 115 Table 4.79: Genome databases market by region, 2007–14 ($m) 115 Table 4.80: Collections market by region, 2007–14 ($m) 116 Table 4.81: Model organism databases market by region, 2007–14 ($m) 116 Table 4.82: Global specialized protein databases market by product, 2007–14 ($m) 117 Table 4.83: Specialized protein databases market by region, 118 Table 4.84: Proteome databases market by region, 2007–14 ($m) 119 Table 4.85: Protein classification databases market by region, 2007–14 ($m) 119 Table 4.86: Specific protein family databases market by region, 2007–14 ($m) 120 Table 4.87: Specialized structural databases market by region, 2007–14 ($m) 120 Table 4.88: Microarray databases market by region, 2007–14 ($m) 121 Table 4.89: Pathway databases market by region, 2007–14 ($m) 121 Table 4.90: 2D-PAGE databases market by region, 2007–14 ($m) 122 Table 4.91: Global general database market by product, 2007–14 ($m) 123 Table 4.92: General database market by region, 2007–14 ($m) 123 Table 4.93: Primary sequence databases market by region, 2007–14 ($m) 124 Table 4.94: Protein sequence databases market by region, 2007–14 ($m) 124 Table 4.95: 3D structure databases market by region, 2007–14 ($m) 125 Table 4.96: Carbohydrate databases market by region, 2007–14 ($m) 125 Table 5.97: Global services market by product function, 2007–14 ($m) 130 Table 5.98: Services market by region, 2007–14 ($m) 130 Table 5.99: Global data analysis services market by product function, 2007–14 ($m) 133 Table 5.100: Data analysis services market by region, 2007–14 ($m) 133 Table 5.101: Genomics data analysis market services by region, 2007–14 ($m) 134 Table 5.102: Proteomics data analysis services market by region, 2007–14 ($m) 135 Table 5.103: Microarray data analysis services market by region, 2007–14 ($m) 135 Table 5.104: Modeling & computational bioinformatics services market by region, 2007–14 ($m) 136 Table 5.105: Global sequencing services market by product function, 2007–14 ($m) 137 Table 5.106: Sequencing services market by region, 2007–14 ($m) 137 Table 5.107: High-throughput sequencing market by region, 2007–14 ($m) 139 Table 5.108: Multiple sequence alignment market by region, 2007–14 ($m) 139 Table 5.109: Resequencing services market by region, 2007–14 ($m) 140 Table 5.110: Primer walking market by region, 2007–14 ($m) 140 Table 5.111: Expression profile clustering and sequence pattern market by region, 2007–14 ($m) 141 Table 5.112: Shotgun sequencing (bacterial artificial chromosomes and cosmids) market by region, 2007–14 ($m) 141 Table 5.113: Global database management market by product function, 2007–14 ($m) 142 Table 5.114: Database management market by region, 2007–14 ($m) 143 Table 5.115: Conception and realization market by region, 2007–14 ($m) 144 Table 5.116: User interface development market by region, 2007–14 ($m) 144 Table 5.117: Maintenance market by region, 2007–14 ($m) 145 Table 5.118: Backup system market by region, 2007–14 ($m) 145 Table 5.119: Migration market by region, 2007–14 ($m) 146 Table 5.120: Other services market by region, 2007–14 ($m) 146 Table 5.121: Other services market by region, 2007–14 ($m) 147 Table 5.122: Security system market by region, 2007–14 ($m) 147 Table 5.123: Data-mining services by region, 2007–14 ($m) 148 Table 5.124: Infrastructure integration services market by region, 2007–14 ($m) 149 Table 5.125: Knowledge management market by region, 2007–14 ($m) 150 Table 6.126: Global applications market by product segment, 2007–14 ($m) 153 Table 6.127: Global molecular medicine market by product segment, 2007–14 ($m) 158 Table 6.128: Global preventive medicine market by product segment, 2007–14 ($m) 161 Table 6.129: Global gene therapy market by product segment, 2007–14 ($m) 163 Table 6.130: Global drug development market by product function, 2007–14 ($m) 165 Table 6.131: Global other applications market by product function, 2007–14 ($m) 168 Table 7.132: Market forecast for bioinformatics by region, 2007–14 ($m) 173 Table 7.133: North American bioinformatics market, 2007–14 ($m) 174 Table 7.134: European bioinformatics market, 2007–14 ($m) 175 Table 7.135: Asian bioinformatics market, 2007–14 ($m) 176 Table 7.136: RoW bioinformatics market, 2007–14 ($m) 185 Table 9.137: US bioinformatics patents 256 Table 9.138: US bioinformatics patents (contd 1) 257 Table 9.139: US bioinformatics patents (contd 2) 258 Table 9.140: US bioinformatics patents (contd 3) 259 Table 9.141: European bioinformatics patents 260 Table 9.142: European bioinformatics patents (contd 1) 261 Table 9.143: European bioinformatics patents (contd 2) 262 Table 9.144: Japanese bioinformatics patents 262 Table 9.145: Japanese bioinformatics patents (contd 1) 263 Table 9.146: Japanese bioinformatics patents (contd 2) 264 Figure 1.1: Bioinformatics components 29 Figure 1.2: Bioinformatics market segmentation 31 Figure 1.3: Market transition impacting bioinformatics market 32 Figure 1.4: Role of bioinformatics in drug development process 33 Figure 1.5: Comparative analysis of the bioinformatics application market 35 Figure 1.6: Relative importance of bioinformatic tool features (2009 vs 2014) 36 Figure 1.7: Market size versus growth in the bioinformatic tools market 37 Figure 1.8: Market size versus growth in the bioinformatic services market 39 Figure 1.9: Patents approved by technology (%), 2004 vs 2008 41 Figure 1.10: Patents approved by company, 2004-08 42 Figure 1.11: Regional approval of patents, 2004 vs 2008 43 Figure 2.12: Strategic focus of bioinformatics companies, 2008-09 48 Figure 3.13: Bioinformatic tools market dynamics 63 Figure 3.14: Level of market attractiveness of bioinformatic tools 65 Figure 3.15: Sequence analysis process and application of bioinformatic tools 68 Figure 4.16: Bioinformatics content/database market dynamics 110 Figure 5.17: Bioinformatics services market dynamics 129 Figure 5.18: Level of attractiveness of the bioinformatics services market 131 Figure 6.19: Regional distribution of bioinformatics applications market, 2009 and 2014 154 Figure 6.20: Global scenario for molecular medicine 159 Figure 6.21: Level of market attractiveness for other bioinformatic applications 168 Figure 7.22: Market revenues for Asia, 2008 vs 2014 177 Figure 7.23: Comparative impact of business environment (India and China), 2009 178 Figure 7.24: Indian bioinformatics market structure 179 Figure 7.25: Source of revenue for Indian bioinformatics firms 180 Figure 7.26: Major opportunities for Indian IT market players 181 Figure 7.27: Business opportunities in India and China 182 Figure 7.28: Key trends impacting India and China 184 [Ocultar lista de tablas / figuras] |
||||||||||||
| Precio ** (Formato del reporte): |
libre de costos de envio **Importante: Todos los precios son netos sin impuestos. Depende del país y de su tipo de empresa para pagar los impuestos. Si usted nos da su dirección de facturación, el monto total correcto será indicado en la siguiente orden de proceso. Para más información de impuestos y precios usted nos encuentra en nuestros FAQs |
|||||||||||
